MedTrace Logo

Evaluation of Everolimus-Eluting Stents (The K-XIENCE Registry)

NCT01350869 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2015-11-11

No results posted yet for this study

Summary

The objective of this study is to evaluate effectiveness and safety of everolimus-eluting stents (XIENCE, Abbott) in the "real world" daily practice as compared with first-generation drug-eluting stents (sirolimus-eluting stents).

Conditions

Interventions

DEVICE

Xience

Patients with Xience

Sponsors & Collaborators

  • CardioVascular Research Foundation, Korea

    collaborator OTHER

  • Abbott

    collaborator INDUSTRY

  • Seung-Jung Park

    lead OTHER

Principal Investigators

  • Seung-Jung Park, MD, PhD · Asan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2011-12-31
Completion
2014-06-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01350869 on ClinicalTrials.gov